Optiver Holding
PRME icon

Optiver Holding’s Prime Medicine PRME Stock Holding History

Optiver Holding’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.1K Buy
892
+732
+458% +$2.79K ﹤0.01% 1647
2025
Q4 		$555 Sell
160
-738
-82% -$3.28K ﹤0.01% 2286
2025
Q3 		$4.97K Buy
+898
New +$3.65K ﹤0.01% 1744

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Optiver Holding's PRME Position: Q1 2026 in Review

Optiver Holding increased its Prime Medicine (PRME) stake by 458% in Q1 2026, buying an estimated $2.79K and bringing the position to 892 shares worth $3.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1647.

Optiver Holding first reported a position in PRME in Q3 2025 and has held it in 3 quarters since. The position peaked at $4.97K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Optiver Holding held 892 shares of Prime Medicine worth $3.1K as of Q1 2026.
  • Optiver Holding bought 732 Prime Medicine shares in Q1 2026, an estimated $2.79K.
  • Prime Medicine made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1647 holding.
  • Optiver Holding first reported a position in Prime Medicine in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Prime Medicine position peaked at $4.97K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.